A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03516266 |
|
Recruitment Status : Unknown
Verified April 2018 by Peking Union Medical College Hospital.
Recruitment status was: Recruiting
First Posted : May 4, 2018
Last Update Posted : May 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Pelvic Floor |
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 7920 participants |
| Observational Model: | Cohort |
| Time Perspective: | Cross-Sectional |
| Target Follow-Up Duration: | 1 Day |
| Official Title: | A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female |
| Actual Study Start Date : | May 10, 2018 |
| Estimated Primary Completion Date : | December 31, 2020 |
| Estimated Study Completion Date : | December 31, 2020 |
- maximum vaginal contraction pressure [ Time Frame: 1 day ]it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.
- Pelvic floor muscle strength [ Time Frame: 1 day ]
The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes.
through vaginal palpation.
- Pelvic floor muscle strength(repetition) [ Time Frame: 1 day ]Levator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.
- Pelvic floor muscle contraction endurance [ Time Frame: 1 day ]muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.
- pelvic organ prolapse quantification [ Time Frame: 1 day ]POP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.
- the knack test [ Time Frame: 1 day ]a voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.
- vaginal rest pressure [ Time Frame: 1 day ]measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Volunteers are divided into three groups, and each clinical center requires at least 120 persons in each group.
Group A: Premenopausal women without history of abortion or delivery.
Group B: Premenopausal women with childbirth (including cesarean section or natural birth).
Group C:Postmenopausal women (except surgical menopause).
Inclusion Criteria:
Group A:Premenopausal women without history of abortion or delivery
- Having sex life and tolerable to vaginal examination
- Premenopausal women without history of abortion over 16 weeks
- Premenopausal women without history of childbirth
- Planning to live locally for a long time
Group B:Premenopausal women with childbirth
- Having sex life and tolerable to vaginal examination
- Premenopausal women with childbirth (including cesarean section or natural birth).
- Planning to live locally for a long time
Group C:Postmenopausal women (over a year, except surgical menopause)
- Having sex life and tolerable to vaginal examination
- Postmenopausal women
- Planning to live locally for a long time
Exclusion Criteria:
- Incontinence 4 weeks before enrollment
- History of fecal incontinence
- Prolapse beyond the level of the hymen
- History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect)
- History of pelvic radiotherapy
- History of pelvic floor surgery
- History of abortion over 16 weeks' pregnancy or in 1 year after delivery
- Duration of pregnancy
- Duration of lactation
- History of hysterectomy
- Latex allergy
- Colpitis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03516266
| Contact: Zhijing Sun, MD | 13651314354 | sunzhj2001@sina.com | |
| Contact: Lan Zhu, MD | zhu_julie@vip.sina.com |
| China, Beiing | |
| Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences | Recruiting |
| Beijing, Beiing, China, 100730 | |
| Contact: Zhijing Sun, MD 13651314354 sunzhj2001@sina.com | |
| Principal Investigator: | Lan Zhu, MD | Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
| Responsible Party: | Peking Union Medical College Hospital |
| ClinicalTrials.gov Identifier: | NCT03516266 |
| Other Study ID Numbers: |
JS-1550 |
| First Posted: | May 4, 2018 Key Record Dates |
| Last Update Posted: | May 11, 2018 |
| Last Verified: | April 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pelvic floor muscle strength Premenopausal nullipara Childbirth Postmenopausal |

